We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$16.9B
AUM Growth
+$10.5B
Cap. Flow
+$12.3B
Cap. Flow %
72.41%
Top 10 Hldgs %
24.17%
Holding
648
New
193
Increased
117
Reduced
69
Closed
177

Sector Composition

Rank Sector Weight
1 Healthcare 3.81%
2 Communication Services 3.67%
3 Financials 3.11%
4 Technology 3.1%
5 Consumer Discretionary 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
301
Arrowhead Research
ARWR
$12.5B
$2.78M 0.02%
84,095
-1,033
-1% -$41.7K
LCTX icon
302
Lineage Cell Therapeutics
LCTX
$286M
$2.69M 0.02%
2,377,940
-44,427
-2% -$65.2K
BKNG icon
303
PUT
Booking.com
BKNG
$160B
$2.63M 0.02%
40,000
+30,000
+300% +$2.25M
CAT icon
304
Caterpillar
CAT
$385B
$2.58M 0.02%
15,723
-16,887
-52% -$3.08M
MRSH
305
Marsh
MRSH
$91B
$2.56M 0.02%
+17,184
New +$2.76M
AMAT icon
306
Applied Materials
AMAT
$415B
$2.54M 0.02%
31,030
+28,178
+988% +$2.72M
DLTR icon
307
CALL
Dollar Tree
DLTR
$24.9B
$2.53M 0.01%
+18,600
New +$2.89M
PH icon
308
Parker-Hannifin
PH
$134B
$2.52M 0.01%
+10,410
New +$2.82M
BSX icon
309
Boston Scientific
BSX
$73.1B
$2.52M 0.01%
64,949
+168
+0.3% +$6.74K
IBM icon
310
IBM
IBM
$223B
$2.48M 0.01%
20,845
+18,344
+733% +$2.41M
CRWD icon
311
CALL
CrowdStrike
CRWD
$229B
$2.47M 0.01%
60,000
CRWD icon
312
PUT
CrowdStrike
CRWD
$229B
$2.47M 0.01%
60,000
CVS icon
313
PUT
CVS Health
CVS
$122B
$2.38M 0.01%
25,000
-45,000
-64% -$4.45M
HOWL icon
314
Werewolf Therapeutics
HOWL
$18.6M
$2.36M 0.01%
522,900
-12,260
-2% -$66.6K
ICVX
315
DELISTED
Icosavax, Inc. Common Stock
ICVX
$2.35M 0.01%
742,354
OMGA
316
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.35M 0.01%
432,700
CRWD icon
317
CrowdStrike
CRWD
$229B
$2.31M 0.01%
56,000
+35,600
+175% +$1.63M
MAR icon
318
Marriott International
MAR
$90.9B
$2.26M 0.01%
+16,150
New +$2.47M
APO icon
319
PUT
Apollo Global Management
APO
$76B
$2.26M 0.01%
+48,600
New +$2.67M
BCAB icon
320
BioAtla
BCAB
$5.76M
$2.25M 0.01%
5,852
CMPS
321
Compass Pathways
CMPS
$1.78B
$2.03M 0.01%
189,407
APO icon
322
Apollo Global Management
APO
$76B
$2.03M 0.01%
+43,682
New +$2.4M
ROK icon
323
PUT
Rockwell Automation
ROK
$48.3B
$2M 0.01%
+9,300
New +$2.17M
ASML icon
324
CALL
ASML
ASML
$666B
$1.99M 0.01%
+4,800
New +$2.4M
FDMT icon
325
4D Molecular Therapeutics
FDMT
$582M
$1.97M 0.01%
245,123

Similar funds

Laurion Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Laurion Capital Management held 648 positions worth $16.9B, up 162% from $6.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $12.3B of net new capital in Q3 2022, opening 193 new positions and adding to 117 existing holdings. Its largest new stake was Adobe: 254,770 shares worth $70.1M.

By sector, the portfolio is most concentrated in Healthcare at 3.8% of assets, down from 12% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $165M trimmed.

  • Laurion Capital Management's largest Q3 2022 buy was Adobe: 254,770 shares worth $70.1M.
  • Laurion Capital Management added most to Alphabet (Google) Class A in Q3 2022, an estimated $215M increase.
  • Laurion Capital Management's biggest Q3 2022 reduction was Lowe's Companies, cutting an estimated $165M.
  • Laurion Capital Management fully exited Warner Bros in Q3 2022, selling an estimated $213M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $16.9B portfolio in Q3 2022.
  • Laurion Capital Management opened 193 new positions and closed 177 in Q3 2022.
  • Laurion Capital Management's portfolio value rose 162% quarter-over-quarter to $16.9B.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.